期刊
JOURNAL OF CELLULAR BIOCHEMISTRY
卷 104, 期 6, 页码 1988-1993出版社
WILEY
DOI: 10.1002/jcb.21363
关键词
nuclear matrix; nuclear structure; tumor markers; biomarkers
资金
- NCI NIH HHS [R29 CA065463, R29 CA065463-04, CA65463, U01 CA084968-01, CA084968, U01 CA084968] Funding Source: Medline
There are few biomarkers that have been developed which have proven clinical utility for the detection and prognosis of cancer. Cancer is diagnosed today, in large part, by examining cells under the microscope and determining the shape and texture of the nucleus. The molecular underpinnings of this hallmark of cancer are the components of the nuclear matrix. Utilizing proteomics focused on this subset of proteins, biomarkers have been identified that are specific for cancer types including prostate, colon and bladder cancer. These cancer biomarkers now serve as the basis of assays which can specifically identify individuals with cancer by sampling their blood and/or urine. In addition, these may serve as potential therapeutic targeting or imaging approaches.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据